Kliininen tutkimuskeskus
Clinical Research Center

Julkaisut 2004
Publications 2004

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Winblad B et al. Mild cognitive impairment - beyond controversies, towards a consensus: report ot the international working group on mild cognitive impairment.
2 Anttila T et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study.
3 Arokoski JPA et al. Estimation of femoral head bone density using magnetic resonance imaging.
4 Autere J et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson´s disease and Parkinson´s disease dementia.
5 Boccardi M et al. APOE and modulation of Alzheimer´s and frontotemporal dementia.
6 Brainin M et al. Organization of stroke care: education, referral, emergency management and imaging, stroke units and rehabilitation.
7 Bunce D et al. Utilization of cognitive support in episidic free recall as a function of apolipoprotein E and vitamin B12 or folate among adults aged 75 years and older.
8 Cuesta-Munoz AL et al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
9 Diener H-C et al. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack of ischaemic stroke (MATCH): Study design and baseline data.
10 Diener H-C et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.
11 Faisel F et al. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation.
12 Gylling H et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorbtion and insulin sensitivity.
13 Haara MM et al. Osteoarthritis in the carpometacarpal joint of the thumb. Prevalence and associations with disability and mortality.
14 Hakulinen MA et al. Ability of ultrasound backscattering to predict mechanical properties of bovine trabecular bone.
15 Hedman A et al. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attridutable to the Asp175Asn mutation in the Alfa-tropomyo.
16 Heikkinen A-M et al. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women .
17 Heinonen S et al. The 121Q allele of the plasma cell membrane glycoprotein 1 gene predisposes to polycystic ovary syndrome.
18 Helisalmi S et al. Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population.
19 Helisalmi S et al. Genetic variation in apolipoprotein D and Alzheimer´s disease.
20 Helisalmi S et al. Polymorphisms in neprilysin gene affect the risk of Alzheimer´s disease in Finnish patients.
21 Hiltunen M et al. Alzheimerin taudin genetiikka.
22 Huopio J et al. Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women.
23 Hänninen T, Soininen H. Muistihäiriöt ja dementia.
24 Iivonen S et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease.
25 Jakovljevic D, on behalf of the FINSTROKE Register Group. Day of the week and ischemic stroke - Is it monday high or sunday low?
26 Jones RW et al. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer´s disease.
27 Jääskeläinen E et al. M385T polymorphism in the factor V gene, but not leiden mutation, is associated with placental abruption in finnish women.
28 Kanis A et al. A meta-analysis of previous fracture and subsequent fracture risk.
29 Kerokoski P et al. Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons.
30 Kröger L et al. Transient bone marrow oedema in a child.
31 Kubaszek A et al. The association of the K121Q polymorphism of the plasma cell glycoprotein-1 gene with type 2 diabetes and hypertension depends on size at birth.
32 Kärkkäinen S et al. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
33 Lane RM et al. Acetylcholinesterase and its inhibition in Alzheimer Disease.
34 Laukkanen O et al. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes.
35 Lehtonen A et al. Declining incidence and mortality of stroke in persons aged > or = 75 years in Finland; the FINSTROKE study.
36 Leys D et al. Prevention.
37 Li X et al. Phosphorylated eukaryotic translation factor 4E is elevated in alzheimer brain.
38 Martikainen J et al. Potential cost-effectiveness of a family based program in mild Alzheimer´s disease patients.
39 Mayhew P et al. Discrimination between cases of hip fracture and controls is improved by hip structural analysis compared to areal bone mineral density. An ex vivo study of the femoral neck.
40 Pennanen C et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD.
41 Pennanen C et al. Serum testosterone levels in males with Alzheimer´s disease.
42 Peurala SH et al. How much exercise does the enhanced gait-oriented physiotherapy provide for chronic stroke patients?
43 Pihlajamäki J et al. The Pro12Ala polymorphism of the PPARgamma2 gene regulates weight from birth to adulthood.
44 Pihlajamäki M. Functional MRI Studies on Human Declarative Memory.
45 Pihlajamäki M et al. Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humans.
46 Pirttilä T, Nybo T. Kipu ja kognitio.
47 Pirttilä T. Muistihäiriöisen ja dementoituvan henkilön kuntoutus: Muistihäiriöisen ja dementoituvan henkilön kuntoutuksen mahdollisuudet.
48 Pirttilä T. Mitä kaikkea minun pitäisi tietää dementiasta?
49 Pirttilä T. Dementia.
50 Pirttilä T et al. Voidaanko muistin heikentymistä ehkäistä?
51 Pirttilä T et al. Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.
52 Pirttilä T et al. Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer´s disease: multicenter trial.
53 Qiu C et al. Risk and protective effects of the APOE gene towards Alzheimer´s disease in the Kungsholmen project: variation by age and sex.
54 Remes T et al. The association of bone metabolism with bone mineral density, serum sex hormone concentrations, and regular exercise in middle-aged men.
55 Rioux JD et al. Genomewide search and association studies in a Finnish celiac disease population: identification of a novel locus and replication of HLA and CTLA4 loci.
56 Rutanen J et al. The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain.
57 Sirola J et al. Factors related to postmenopausal muscle performance: a cross-sectional population-based study.
58 Sivenius J, Jolkkonen J. Uutta näyttöä aivohalvauskuntoutuksen vaikutuksista.
59 Sivenius J et al. Continuous 15-year decrease in incidence and mortality of stroke in Finland. The FINSTROKE Study.
60 Sivenius J et al. FINSTROKE-tutkimus: Aivohalvauksen ilmaantuvuus ja kuolleisuus laskivat Suomessa vuosina 1983-1997.
61 Soininvaara TA et al. Bone mineral density in the proximal femur and contralateral knee after total knee arthroplasty.
62 Soininvaara TA et al. Periprosthetic femoral bone loss after total knee arhtroplasty: 1-year follow-up study of 69 patients.
63 Soininvaara TA et al. Periprosthetic tibial bone mineral density changes after total knee arthroplasty.
64 Suuriniemi M et al. Association between exercise and pubertal BMD is modulated by estrogen receptor alfa genotype.
65 Temelkova-Kurktschiev T et al. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.
66 Tervo S et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects.
67 Testa C et al. A comparison between the accurancy of voxel-based morphometry and hippocampal volumetry in Alzheimer`s disease.
68 Todorova B et al. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
69 Toivonen S et al. Low-activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption.
70 Turunen V et al. Työikäisten potilaiden lonkan tekonivelleikkausten sairaalahoito- ja päivärahakustannukset.
71 Turunen V et al. Polven nivelrikko työikäisillä.
72 Virtanen T et al. Re: External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats.
73 Voutilainen S et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
74 Wolf H et al. Serum lipids and hippocampal volume: the link to Alzheimer´s disease?
75 Yavich L et al. Role of alfa-synuclein in presynaptic dopamine recruitment .
76 Yliharsila H et al. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication.

Kliininen tutkimuskeskus Clinical Research Center
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008